Mayne Pharma Group Limited (HG6.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:09AM CEST. Market open.
| Previous close | 2.9600 |
| Open | 2.9600 |
| Bid | 0.0000 x 1000000 |
| Ask | 0.0000 x 1000000 |
| Day's range | 2.9600 - 2.9600 |
| 52-week range | 1.6300 - 4.4400 |
| Volume | |
| Avg. volume | 2 |
| Market cap | 255.719M |
| Beta (5Y monthly) | 1.32 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 18 Jan 2023 |
| 1y target est | N/A |
- Simply Wall St.
ASX Growth Companies With Insider Ownership As High As 35%
The Australian stock market has shown positive momentum, rising 1.5% in the past week and achieving a 7.3% increase over the last year, with earnings expected to grow by 13% annually. In this buoyant environment, growth companies with high insider ownership can be particularly compelling, as they often signal strong confidence from those closest to the business.
- Simply Wall St.
Mayne Pharma Group Limited's (ASX:MYX) largest shareholders are individual investors with 38% ownership, institutions own 33%
Key Insights Significant control over Mayne Pharma Group by individual investors implies that the general public has...
- Simply Wall St.
Favourable Signals For Mayne Pharma Group: Numerous Insiders Acquired Stock
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...
© 2024 Yahoo. All rights reserved.